How does the USPTO handle conflicting instructions in patent application submissions?

The USPTO has specific procedures for handling conflicting instructions in patent application submissions: As per 37 CFR 1.495(g), applications with conflicting instructions regarding treatment under 35 U.S.C. 111(a) or 371 will be treated as national stage submissions under 35 U.S.C. 371. The MPEP states: “Where applicant’s initial submission under 35 U.S.C. 371 contains conflicting instructions…

Read More

What is the scope of MPEP Chapter 800?

MPEP Chapter 800 focuses on restriction and double patenting in national applications filed under 35 U.S.C. 111(a). The chapter states: “This chapter is limited to a discussion of the subjects of restriction and double patenting under Title 35 of the United States Code and Title 37 of the Code of Federal Regulations as it relates…

Read More

What is the difference between a 35 U.S.C. 111(a) application and a 35 U.S.C. 371 national stage application?

The key difference lies in the filing process and requirements: 35 U.S.C. 111(a) application: A direct U.S. patent application. 35 U.S.C. 371 national stage application: Enters the U.S. national stage from an international PCT application. The MPEP states: “If the initial submission does not include any indication that the submission is made under 35 U.S.C.…

Read More

Can a CPA be filed in a provisional application?

Can a CPA be filed in a provisional application? No, a Continued Prosecution Application (CPA) cannot be filed in a provisional application. The MPEP 201.06(d) clearly states: A continuation or divisional application may be filed under 37 CFR 1.53(d) if the prior application is a design application, but not an international design application, that is…

Read More

Can a divisional or continuation application claim benefit from multiple prior applications?

Yes, a divisional or continuation application can claim benefit from multiple prior applications. The MPEP 201.06(c) states: ‘A continuation or divisional application may be filed under 35 U.S.C. 111(a) using the procedures set forth in 37 CFR 1.53(b), by providing: (A) a copy of the prior application as filed; and (B) a new specification, claim…

Read More

What is the significance of 35 U.S.C. 111(a) and (b) in national patent applications?

35 U.S.C. 111(a) and (b) are important sections of the patent law that define two different types of national patent applications. According to MPEP 201.01: ‘National applications may be filed under 35 U.S.C. 111(a) or (b), 161, or 171.’ To elaborate: 35 U.S.C. 111(a) refers to nonprovisional applications. These are full patent applications that can…

Read More

What is the deadline for filing a benefit claim under 35 U.S.C. 119(e), 120, 121, 365(c), or 386(c)?

The deadline for filing a benefit claim depends on the type of application: For applications filed under 35 U.S.C. 111(a), the reference must be submitted within the later of: Four months from the actual filing date of the application, or Sixteen months from the filing date of the prior application For nonprovisional applications entering the…

Read More